Full Text
Full Text PDF
Abstract
Hyponatremia is defined as a serum sodium level of <135 mEq/l, and it is an important clinical entity that increases mortality and morbidity when not treated. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is the most common cause of the normovolemic hyponatremia. SIADH may occur in a variety of clinical entity and also as an adverse effect secondary to many drugs. Sodium valproate, an agent widely used for the treatment of schizoaffective disorder, bipolar disorder and epilepsy, rarely cause SIADH and hyponatremia as an adverse effect. The mechanism of sodium valproate associated SIADH and hyponatremia is not exactly known. We aimed to present a case of hyponatremia and SIADH due to repeated use of sodium-valproate and to review the relevant literature.
Similar Articles
Similar Articles
- Antipsychotic Treatment Patterns and Associated Clinical Characteristics in Schizophrenia: A Multicenter Study from Community Mental Health Centers in Türkiye
- Clinical and Forensic Characteristics of Homicide Offenders With Bipolar Disorder: A Retrospective Study From a National Forensic Psychiatry Center
Article Info
Published In
Journal
Neuropsychiatric Investigation
Volume / Issue
Volume 56 · Issue 4
Pages
18-21
History
Published Online
September 1, 2018
Copyright
Copyright (c) 2018 Neuropsychiatric Investigation
Affiliations
Ömer Asan
Erol Göka
Cite this Article
Asan, Ömer, & Göka, E. (2018). The Syndrome of Inappropriate Secretion of Antidiuretic Hormone and Hyponatremia due to Sodium Valproate Treatment; A Case Report and Review of the Literature. Neuropsychiatric Investigation, 56(4), 18–21. https://doi.org/10.5455/NYS.20190104035535
Outlines